PMC:7755033 / 57141-57320 JSONTXT

Annnotations TAB JSON ListView MergeView

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/7755033","sourcedb":"PMC","sourceid":"7755033","source_url":"https://www.ncbi.nlm.nih.gov/pmc/7755033","text":"Binding energies of WS phytoconstituents with SARS–CoV main protease/3CL-pro (PBB ID: 1P9U) in comparison to the FDA approved standard reference drugs (Oberadilol and Poziotinib).","tracks":[{"project":"LitCovid-PubTator","denotations":[{"id":"880","span":{"begin":46,"end":54},"obj":"Species"},{"id":"881","span":{"begin":20,"end":22},"obj":"Species"},{"id":"882","span":{"begin":152,"end":162},"obj":"Chemical"},{"id":"883","span":{"begin":167,"end":177},"obj":"Chemical"}],"attributes":[{"id":"A880","pred":"tao:has_database_id","subj":"880","obj":"Tax:694009"},{"id":"A881","pred":"tao:has_database_id","subj":"881","obj":"Tax:126910"},{"id":"A883","pred":"tao:has_database_id","subj":"883","obj":"MESH:C557213"},{"subj":"880","pred":"source","obj":"LitCovid-PubTator"},{"subj":"881","pred":"source","obj":"LitCovid-PubTator"},{"subj":"882","pred":"source","obj":"LitCovid-PubTator"},{"subj":"883","pred":"source","obj":"LitCovid-PubTator"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}]},{"project":"LitCovid-sentences","denotations":[{"id":"T532","span":{"begin":0,"end":85},"obj":"Sentence"},{"id":"T533","span":{"begin":86,"end":179},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T532","pred":"source","obj":"LitCovid-sentences"},{"subj":"T533","pred":"source","obj":"LitCovid-sentences"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"LitCovid-PubTator","color":"#93ece2","default":true},{"id":"LitCovid-sentences","color":"#ecc893"}]}]}}